1. Home
  2. HTCR vs ATNM Comparison

HTCR vs ATNM Comparison

Compare HTCR & ATNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HTCR
  • ATNM
  • Stock Information
  • Founded
  • HTCR 2009
  • ATNM 2000
  • Country
  • HTCR Japan
  • ATNM United States
  • Employees
  • HTCR N/A
  • ATNM N/A
  • Industry
  • HTCR EDP Services
  • ATNM Biotechnology: Pharmaceutical Preparations
  • Sector
  • HTCR Technology
  • ATNM Health Care
  • Exchange
  • HTCR Nasdaq
  • ATNM Nasdaq
  • Market Cap
  • HTCR 48.1M
  • ATNM 46.5M
  • IPO Year
  • HTCR 2022
  • ATNM N/A
  • Fundamental
  • Price
  • HTCR $0.84
  • ATNM $1.86
  • Analyst Decision
  • HTCR
  • ATNM Strong Buy
  • Analyst Count
  • HTCR 0
  • ATNM 4
  • Target Price
  • HTCR N/A
  • ATNM $8.75
  • AVG Volume (30 Days)
  • HTCR 87.3K
  • ATNM 1.3M
  • Earning Date
  • HTCR 05-13-2025
  • ATNM 04-25-2025
  • Dividend Yield
  • HTCR 4.67%
  • ATNM N/A
  • EPS Growth
  • HTCR N/A
  • ATNM N/A
  • EPS
  • HTCR 0.23
  • ATNM N/A
  • Revenue
  • HTCR $30,290,930.00
  • ATNM $81,000.00
  • Revenue This Year
  • HTCR $53.30
  • ATNM $138.42
  • Revenue Next Year
  • HTCR N/A
  • ATNM $16,957.05
  • P/E Ratio
  • HTCR $3.69
  • ATNM N/A
  • Revenue Growth
  • HTCR 47.63
  • ATNM N/A
  • 52 Week Low
  • HTCR $0.55
  • ATNM $1.03
  • 52 Week High
  • HTCR $3.38
  • ATNM $10.24
  • Technical
  • Relative Strength Index (RSI)
  • HTCR 40.92
  • ATNM 69.95
  • Support Level
  • HTCR $0.95
  • ATNM $1.16
  • Resistance Level
  • HTCR $1.10
  • ATNM $1.30
  • Average True Range (ATR)
  • HTCR 0.09
  • ATNM 0.13
  • MACD
  • HTCR 0.01
  • ATNM 0.05
  • Stochastic Oscillator
  • HTCR 42.86
  • ATNM 43.22

About HTCR Heartcore Enterprises Inc.

HeartCore Enterprises Inc is a software development company. It provides software through two business units. The first business unit includes a customer experience management business that has been in existence for 12 years. The customer experience management platform includes marketing, sales, service and content management systems, as well as other tools and integrations, that enable companies to attract and engage customers throughout the customer experience. It also provides education, services and support to help customers be successful with the CXM Platform. The second business unit, its DX division, is a digital transformation business that provides customers with robotics process automation, process mining and task mining to accelerate the digital transformation of enterprises.

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.

Share on Social Networks: